METT11D1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.017800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.420980E-01
Normal-vs-Stage2
1.037830E-02
Normal-vs-Stage3
3.647600E-02
Normal-vs-Stage4
1.361620E-01
Stage1-vs-Stage2
9.221800E-01
Stage1-vs-Stage3
8.414300E-02
Stage1-vs-Stage4
6.784400E-01
Stage2-vs-Stage3
2.018200E-02
Stage2-vs-Stage4
5.315600E-01
Stage3-vs-Stage4
1.356550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.797100E-03
Normal-vs-AfricanAmerican
4.512200E-02
Normal-vs-Asian
9.687800E-02
Caucasian-vs-AfricanAmerican
2.463200E-01
Caucasian-vs-Asian
6.964800E-01
AfricanAmerican-vs-Asian
2.303000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.094000E-02
Normal-vs-Female
1.000320E-02
Male-vs-Female
8.542800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.121200E-01
Normal-vs-Age(41-60Yrs)
2.020400E-02
Normal-vs-Age(61-80Yrs)
7.204700E-03
Normal-vs-Age(81-100Yrs)
3.827400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.178200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.053600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.334800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.319160E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.602800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.252840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.491680E-02
Normal-vs-Daily Drinker
8.618000E-02
Normal-vs-Weekly Drinker
4.648400E-02
Normal-vs-Occasional Drinker
1.165840E-01
Normal-vs-Social Drinker
8.856300E-02
Non Drinker-vs-Daily Drinker
1.971960E-01
Non Drinker-vs-Weekly Drinker
9.538800E-01
Non Drinker-vs-Occasional Drinker
4.013000E-01
Non Drinker-vs-Social Drinker
4.105000E-01
Daily Drinker-vs-Weekly Drinker
3.312600E-01
Daily Drinker-vs-Occasional Drinker
7.939000E-01
Daily Drinker-vs-Social Drinker
7.659200E-01
Weekly Drinker-vs-Occasional Drinker
5.402200E-01
Weekly Drinker-vs-Social Drinker
5.343400E-01
Occasional Drinker-vs-Social Drinker
9.794400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.433800E-01
Normal-vs-Grade 2
8.325400E-01
Normal-vs-Grade 3
7.530200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.926800E-01
Grade 1-vs-Grade 3
3.546200E-01
Grade 1-vs-Grade 4
6.433800E-01
Grade 2-vs-Grade 3
1.326640E-01
Grade 2-vs-Grade 4
8.325400E-01
Grade 3-vs-Grade 4
7.530200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.420800E-01
Normal-vs-NonDiabetic
1.738420E-02
Diabetic-vs-NonDiabetic
9.252000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.930000E-01
Normal-vs-NoPancreatitis
6.896600E-03
Pancreatitis-vs-NoPancreatitis
8.495200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.760800E-01
Normal-vs-N1
1.167990E-02
N0-vs-N1
7.607000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.952200E-01
Normal-vs-TP53-NonMutant
7.256400E-02
TP53-Mutant-vs-TP53-NonMutant
4.754600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
